Cagrilintide/semaglutide
A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglu
Novo Nordisk · Phase 2 · Completed · Enrollment 626
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| CagriSema | n/r | n/r | n/r | n/r | n/r |
| Semaglutide | n/r | n/r | n/r | n/r | n/r |
| Cagrilintide | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.